# Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

> **NCT06222476** · NA · NOT_YET_RECRUITING · sponsor: **Yan Bi** · enrollment: 106 (estimated)

## Conditions studied

- Diabetic Nephropathy Type 2

## Interventions

- **DRUG:** Dorzagliatin
- **DRUG:** Gliclazide

## Key facts

- **NCT ID:** NCT06222476
- **Lead sponsor:** Yan Bi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-02-20
- **Primary completion:** 2025-05-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06222476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06222476, "Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06222476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*